TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited has announced an amendment to its Dividend Reinvestment Plan (DRP) Rules, effective immediately. This change impacts all DRP participant shareholders, indicating a strategic move to potentially enhance shareholder value and streamline dividend processes, reflecting the company’s commitment to maintaining robust shareholder relations.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services across Australasia. The company focuses on distributing healthcare, medical, and pharmaceutical products, as well as offering animal care solutions, positioning itself as a key player in these markets.
Average Trading Volume: 140,909
Technical Sentiment Signal: Sell
Current Market Cap: A$5.07B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.